Search

everythinglearnresearchcommunity

for

Search:↓

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

PRP shows promise in treating joint and spine issues, but translating lab results to humans is challenging.

The conference concluded with plans for joint research into children's skin conditions and emphasized the importance of collaboration and patient-focused research.

Early symptoms of SLE include fatigue, joint pain, and sensitivity to sunlight.

A woman with undifferentiated connective tissue disease was diagnosed with renal amyloidosis and carpal tunnel syndrome.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Lupus can be a rare cause of high calcium levels in the blood.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Tofacitinib is a promising treatment for children with rheumatic diseases.

A 44-year-old woman with Down's syndrome was diagnosed with both rheumatoid and gouty arthritis and treated with multiple medications.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

A small forehead lesion led to the discovery of a significant brain arteriovenous malformation in a young girl.

A woman with Lupus Vasculitis improved after treatment with steroids and other medications.

Careful diagnosis and management of MCTD are crucial due to potential severe complications.

SLE and DM can coexist but are rare and need careful evaluation.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.